Pneumococcal Vaccines: Clinical Trials

5 trials for Pneumococcal Vaccines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 23Completed 3

Follow Pneumococcal Vaccines: new trials by email Literature Review of Pneumococcal Vaccines trials Research Report on Pneumococcal Vaccines

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine
26-Valent pneumococcal conjugate vaccine, 23-Valent pneumococcal polysaccharide vaccine, 13-Valent pneumococcal conjugate vaccine - Pneumococcal Vaccines
Phase 1 / Phase 2CompletedBeijing Zhifei Lvzhu Biopharmaceutical Co., Ltd4502025-07-172026-03-30
Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults
31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate vaccine - Pneumococcal Vaccines
Phase 1 / Phase 2CompletedVaxcyte, Inc.10152023-11-082025-07-28
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
IVT PCV-25, PCV 20 - Pneumococcal Vaccines
Phase 1CompletedInventprise Inc.652022-09-282023-08-30
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
24 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate vaccine - Pneumococcal Vaccines
Phase 1 / Phase 2CompletedVaxcyte, Inc.8352022-02-222024-04-18
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
Placebo, SPWCV+Alum 100 mcg, SPWCV+Alum 600 mcg - Pneumococcal Vaccines
Phase 1CompletedPATH Vaccine Solutions422012-02-012014-06-05

Interventions

23-valent pneumococcal capsular polysaccharide vaccine (1)

Sponsors

Vaxcyte, Inc. (2)  ·  Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1)  ·  Inventprise Inc. (1)  ·  PATH Vaccine Solutions (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)

Top investigators

Joanne Langley, MD, MSc, FRCPC (1)  ·  Royce Morrison, M.D. (1)

Results publications

PMID 30592459, PMID 31895881, PMID 38061367, PMID 41576705, PMID 41864214